IJCRR - 6(2), January, 2014
NOSOCOMIAL PNEUMONIA IN MECHANICALLY VENTILATED - A MULTIVARIATE ANALYSIS
Author: Rashmi M., Shaik Mohammed Usman
Background: The most frequent infection in ICUs, Ventilator-associated pneumonia (VAP); potentially life threatening, stands for another challenge in medicine. Earliness in diagnosis is pivotal. Constant surveillance is crucial to confront the issue by defining expedient strategies. Purpose: The study intended to present our experience in the intensive care units (ICUs) of causative organisms of VAP and their antimicrobial susceptibility profile, with the effect of different variables; utilising this data to devise more pertinent empirical therapy. Methodology: A prospective clinico-microbiological review of patients mechanically ventilated for ?48 hrs and in agreement with a clinical criteria, at a tertiary care set up, from multidisciplinary ICUs was undertaken by standard microbiological techniques. Antimicrobial resistance was patterned. Results: Occurrence of VAP was 49.07%. Late onset type (65.28%) was more frequent. Majority (85.95%) were caused by Gram Negative bacteria (GNB). Acinetobacter baumannii (30.58%) was most regular, followed by Pseudomonas aeruginosa (27.27%). 15 isolates (4 Escherichia coli, 9 Klebsiella spp., 2 Enterobacter spp.) produced ESBL (Extended Spectrum beta lactamase). 1 MRSA (Methicillin resistant Staphylococcus aureus) was isolated. Cases of OP (Organophosporous) poisoning- 31.48%; associated advancing age (>60 years) - 45.28%, Diabetes mellitus - 26.39% and COPD - 22.68% were pre-eminent. Conclusions: Monitoring trends of drug profile of the causative agents is of cardinal benefit for restricting the use of empiric broad spectrum antimicrobials which predisposes to colonization. Constant evaluation of current practice on basis of antibiotic consumption patterns, timely availability of data and programs to reduce or alter antibiotic-prescribing practices is crucial to avert the terrible impact of antimicrobial resistance.
Keywords: Ventilator associated pneumonia, Intensive care units, Gram negative bacteria, Acinetobacter baumannii, Pseudomonas aeruginosa.
Rashmi M., Shaik Mohammed Usman. NOSOCOMIAL PNEUMONIA IN MECHANICALLY VENTILATED - A MULTIVARIATE ANALYSIS International Journal of Current Research and Review. 6(2), January, 40-47
1. Chastre J, Fagon JY. Ventilator-associated pneumonia. Am J Respir Crit Care Med 2002;165:867-903.
2. Campbell GD, Niederman MS, Broughton MA, Craven DE, Fein AM, Fink MP et al American Thoracic Society. Hospital-acquired pneumonia in adults: diagnosis, assessment of severity, initial antimicrobial therapy, and preventive strategies. A consensus statement. Am J Respir Crit Care Med 1995;153:1711- 25.
3. Ewig S, Bauer T, Torres A. The pulmonary physician in critical care: Nosocomial pneumonia. Thorax 2002;57:366-71.
4. Bergmans DC, Bonten MJ, van Tiel FH. Cross-colonization with Pseudomonas aeruginosa of patients in an intensive care unit. Thorax 1998;53:1053-58.
5. Rosenthal VD, Maki DG, Salomao R, Moreno CA, Mehta Y, Higuer F et al. Deviceassociated nosocomial infections in 55 intensive care units of 8 developing countries. Ann Intern Med 2006;145:582-91.
6. Arindam Dey, Indira Bairy. Incidence of multidrug resistant organisms causing ventilator- associated pneumonia in a tertiary care hospital: A nine months prospective study. Annals of thoracic medicine 2007;2:52- 7.
7. Girish L. Dandagi. Nosocomial pneumonia in critically ill patients. Lung India 2010;27:149- 53.
8. Yaseen Arabi, Nehad Al-Shirawi, Ziad Memish, Antonio Anzueto. Ventilatorassociated pneumonia in adults in developing countries: a systematic review. International journal of infectious diseases 2008;12:505-51.
9. Heyland DK, Cook DJ, Marshall J, Heule M, Guslits B, Lang J et al. Canadian Critical Care Trials Group. The clinical utility of invasive diagnostic techniques in the setting of ventilator-associated pneumonia. Chest 1999;115:1076-84.
10. Fabregas N, Ewig S, Torres A, El-Ebiary M, Ramirez J, Puig de la Bellacasa et al. Clinical diagnosis of ventilator associated pneumonia revisited, comparative validation using immediate post-mortem lung biopsies. Thorax 1999;54:867-73.
11. Johanson WG, Pierce Ak, Sandford JP. Nosocomial respiratory infections with gramnegative bacilli: the significance of colonization of the respiratory tract. Ann Intern Med 1972;77:701–6.
12. Koneman EW, Allen SD, Janda WM, Schreckberger PC, Winn CW Jr. The Enterobacteriaceae. In: Colour Atlas and textbook of diagnostic Microbiology. 5th ed. PA: Lippincott Williams and Wilkins Company; 1997. p. 171?252.
13. Jagadish Chander, Textbook of medical mycology 3rd ed. (Mehta Publishers, New Delhi) 2009. p.no. 53-67.
14. CLSI. Performance Standards for Antimicrobial Susceptibility Testing: TwentyThird Infromational Supplement. CLSI Document M100?S23. Wayne PA: Clinical and Laboratory Standards Institute; 2013.
15. Cook DJ, Walter SD, Cook RJ, Griffith LE, Guyatt GH, Leasa D et al. Incidence of and risk factors for ventilator-associated pneumonia in critically ill patients. Ann Intern Med 1998;129:433-40.
16. Apostolopoulou E, Bakakos P, Katostaras T, Gregorakos L. Incidence and risk factors for ventilator-associated pneumonia in 4 multidisciplinary intensive care units in Athens, Greece. Respir Care 2003;48:681-8.
17. Rosenthal VD, Guzman S, Orellano PW. Nosocomial infections in medical-surgical intensive care units in Argentina: attributable mortality and length of stay. Am J Infect Control 2003;31:291-95.
8. Trivedi TH ,Shejale SB, Yeolekar ME. Nosocomial pneumonia in Medical intensive care unit. JAPI 2000;48:1070-73.
19. Panwar Rakshit P, Nagar VS, Deshpande AK. Incidence, clinical outcome and risk stratification of ventilator-associated pneumonia: a prospective cohort study. Indian J Crit Care Med 2005;9:211-6.
20. Hina Gadani, Arun Vyas, Akhya Kumar. A study of ventilator-associated pneumonia: Incidence, outcome, risk factors and measures to be taken for prevention. Indian J Anaesth 2010;54:535-40.
21. Noyal Mariya Joseph, Sujatha Sistla, Tarun Kumar Dutta- Ventilator-associated pneumonia in a tertiary care hospital in India: role of multi-drug resistant pathogens. J Infect Dev Ctries 2010;4:218-25.
22. Mukhopadhyay C, Bhargava A, Ayyagari A. Role of mechanical ventilation and development of multidrug resistant organisms in hospital acquired pneumonia. Indian J Med Res 2003;118:229-35.
23. Bergmans DC, Bonten MJ, van Tiel FH. Cross-colonization with Pseudomonas aeruginosa of patients in an intensive care unit. Thorax 1998;53:1053-8.
24. Nidhi Goel, Uma Chaudhary, Ritu Aggarwal, Kiran Bala. Antibiotic sensitivity pattern of gram negative bacilli isolated from the lower respiratory tract of ventilated patients in the intensive care unit. Indian J Crit Care Med 2009;13:148-51.